Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-051719
Filing Date
2021-08-16
Accepted
2021-08-16 20:00:34
Documents
2
Period of Report
2021-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5897
2 POA DOCUMENT poa.txt EX-24.3_1004146 3279
  Complete submission text file 0001209191-21-051719.txt   10679
Mailing Address 1333 S. SPECTRUM BLVD #100 CHANDLER AZ 85286
Business Address
Vanhove Geertrui (Reporting) CIK: 0001771994 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39635 | Film No.: 211180568

Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Issuer) CIK: 0001824893 (see all company filings)

EIN.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)